Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.
暂无分享，去创建一个
Jeffrey W. Clark | K. Lillemoe | R. Jain | Y. Boucher | B. Yeap | A. Zhu | D. Ryan | T. Delaney | T. Hong | R. Nipp | Wenqing Jiang | C. Ferrone | A. Parikh | L. Goyal | C. F. Castillo | Jill N. Allen | L. Blaszkowsky | Janet E. Murphy | J. Wo | G. Duda